Gritstone Bio Inc (GRTS)
0.80
-0.01
(-0.76%)
USD |
NASDAQ |
Apr 30, 16:00
0.8099
+0.01
(+1.24%)
After-Hours: 05:01
Gritstone Bio Cash from Investing (Quarterly): 38.30M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.30M |
| September 30, 2023 | 18.28M |
| June 30, 2023 | 24.59M |
| March 31, 2023 | 21.17M |
| December 31, 2022 | -46.15M |
| September 30, 2022 | 3.075M |
| June 30, 2022 | 22.48M |
| March 31, 2022 | 7.634M |
| December 31, 2021 | -46.63M |
| September 30, 2021 | 41.16M |
| June 30, 2021 | -23.49M |
| March 31, 2021 | -89.60M |
| Date | Value |
|---|---|
| December 31, 2020 | 11.62M |
| September 30, 2020 | 15.73M |
| June 30, 2020 | 23.82M |
| March 31, 2020 | 14.77M |
| December 31, 2019 | -41.35M |
| September 30, 2019 | 33.98M |
| June 30, 2019 | 21.78M |
| March 31, 2019 | 1.43M |
| December 31, 2018 | -91.46M |
| September 30, 2018 | 15.00M |
| June 30, 2018 | 11.58M |
| March 31, 2018 | 5.778M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-89.60M
Minimum
Mar 2021
41.16M
Maximum
Sep 2021
2.694M
Average
15.73M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Precision BioSciences Inc | 0.042M |
| Humacyte Inc | -0.15M |
| Verastem Inc | 12.44M |
| BioVie Inc | 0.00 |
| Syros Pharmaceuticals Inc | 1.522M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.51M |
| Cash from Financing (Quarterly) | 15.72M |
| Free Cash Flow | -126.22M |
| Free Cash Flow Per Share (Quarterly) | -0.1678 |
| Free Cash Flow to Equity (Quarterly) | -29.98M |
| Free Cash Flow Yield | -136.6% |